Schrodinger, Inc.

SDGR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $255.9M $207.5M $216.7M $181.0M $137.9M $108.1M $85.5M
Cost of Revenue $113.3M $75.5M $76.0M $79.9M $72.3M $44.6M $36.5M
Gross Profit $142.6M $132.1M $140.7M $101.0M $65.6M $63.5M $49.1M
Gross Margin 55.7% 63.6% 64.9% 55.8% 47.6% 58.7% 57.4%
Operating Expenses
Research & Development $173.1M $201.8M $181.8M $126.4M $90.9M $64.7M $39.4M
SG&A Expense $95.4M $99.7M $99.1M $90.8M $64.0M $41.9M $27.0M
Operating Income $-166.9M $-209.3M $-177.4M $-146.8M $-111.4M $-60.9M $-38.7M
Operating Margin -65.2% -100.8% -81.9% -81.1% -80.8% -56.4% -45.3%
Interest Expense
Pretax Income $-102.3M $-185.7M $42.9M $-149.1M $-100.8M $-26.3M $-26.0M
Income Tax Expense $939.0K $1.4M $2.2M $63.0K $411.0K $345.0K $-291.0K
Net Income $-103.3M $-187.1M $40.7M $-149.2M $-100.4M $-24.5M $-24.6M
Net Margin -40.4% -90.2% 18.8% -82.4% -72.8% -22.6% -28.7%
EPS (Basic) $-1.41 $-2.57 $0.57 $-2.10 $-1.42 $-0.41 $-4.09
EPS (Diluted) $-1.41 $-2.57 $0.54 $-2.10 $-1.42 $-0.41 $-4.09
Shares Outstanding (Basic) 73.4M 72.7M 71.8M 71.2M 70.6M 60.0M 6.1M
Shares Outstanding (Diluted) 73.4M 72.7M 75.0M 71.2M 70.6M 60.0M 6.1M
Dividends Per Share